Work

Abstract PS5-02-01: Efficacy of cross-line therapy with anti-HER2 TKI in HER2-positive MBC: a multicenter real-world study

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-02-01

Authors: R. Song, Y. Fan, B. Xu, B. Lan, F. Ma

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129768684

Cites:

Cited by:

Related to: